Cocarboxylase Tetrahydrate is a bioactive compound, operating as a proficient biomedical remedy for diverse metabolic intricacies, predominantly encompassing thiamine insufficiency. Operating in tandem with metabolic courses within the organism, this remarkable coenzyme actively facilitates the vital conversion of carbohydrates into substantial energy units.

Gadobenate Dimeglumine is a gadolinium-based paramagnetic contrast agent. When placed in a magnetic field, gadobenate dimeglumine produces a large magnetic moment and so a large local magnetic field, which can enhance the relaxation rate of nearby protons;

Ligustrazine Hydrochloride has certain protection effect on the vascular endothelium undergoing CPB, and lower excessive activation of coagulation reaction and inflammation reaction in patients undergoing CPB.

Trelagliptin is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D).

Omadacycline is a new tetracycline antibiotic in the pipeline, which can inhibit the 30s subunit of bacterial ribosome.

An isoquinoline derivative that is used as a short-acting non-depolarizing agent.

Eldecalcitol (ED-71), a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis. Eldecalcitol, effectively and safely increased lumbar and hip bone mineral density (BMD) in osteoporotic patients who also received vitamin D3 supplementation.